Risultati per: Linee guida su HIV, epatite e malattie sessualmente trasmissibili.

This Viewpoint discusses the need to develop products, such as long-acting antiretrovirals, for people with HIV in settings with minimal resource requirements.

In memoria di Fabio Duchini, i ricavati alla fondazione Telethon

Introduction
Climate change and HIV are interconnected epidemics that increase vulnerability in people living with HIV (PLWH), particularly in sub-Saharan Africa. Despite their public health significance, research on the synergistic effects of these epidemics on the health of PLWH is limited. The advancement of non-invasive wearable technology offers an opportunity to leverage objective health data for large-scale research, addressing this knowledge gap. This study will examine the impact of weather events on distinct health variables of PLWH within the Siaya Health and Demographic Surveillance System (HDSS) in rural Kenya.

Methods and analysis
Over a period of 6 months, we continuously monitored health parameters of a total of 200 participants including heart rate, activity and sleep, using consumer-grade wearable devices. We will correlate these health data with real-time weather parameters (ambient temperature, wet bulb globe temperature, precipitation level) from five weather stations within the HDSS area and compare between HIV-positive participants and an HIV-negative control group. Additionally, a convergent mixed-methods approach will explore participants’ perceptions of the impact of weather events on their health and personal experiences. The study aims to inform future research on the complex relationship between HIV and weather events, which are projected to increase in frequency in this region due to climate change and provide valuable insights for policymakers to develop effective measures to protect this vulnerable population amid the growing climate crisis.

Ethics and dissemination
This study has been approved by the Research Ethics Committees at Kenya Medical Research Institute, Nairobi (approved on 23 October 2023; SERU 4826) and Heidelberg University Hospital, Germany (approved on 14 February 2023; S-824/2022). Written informed consent was obtained from all participants prior to enrolment, with data anonymised and handled according to Kenyan and German data protection regulations. Research findings will be disseminated through peer-reviewed publications and presented at scientific conferences.

Dr. Paul Sax discusses the changes at ACIP in HIV and ID Observations.

Objectives
The New York City (NYC) HIV Care Coordination Programme (CCP) is designed to help people with HIV (PWH) overcome barriers to care and treatment engagement. We assessed preferences for CCP components among programme enrollees (’clients’) and providers. Our objective is to compare client and provider preferences, which were previously analysed separately.

Design
We used a discrete choice experiment to assess preferences for four CCP features (‘attributes’): Help with Adherence to Antiretroviral Therapy (ART), Help with Primary Care Appointments, Help with Issues other than Primary Care and Where Programme Visits Happen. Each of these attributes had 3–4 variants (‘levels’). In the original surveys, levels within Where Programme Visits Happen varied by participant type (client vs provider). We recoded the levels by visit location (VL) or by travel time (TT) to make them comparable and report results from both approaches.

Setting
25 Ryan White Part A-funded NYC CCPs participated.

Participants
152 providers and 181 clients completed the survey.

Primary and secondary outcome measures
Preferences were quantified using the relative importance of the attributes and utility of the levels.

Results
From January 2020 to March 2021, 152 providers and 181 clients completed the survey. Most of the providers (52%) were

Occorre garantire che ogni persona indipendentemente dall’età o dalla rarità della sua condizione riceva l’attenzione e le cure che merita: solo così potremo costruire un sistema sanitario e sociale davvero equo per tutti e sostenibile

Promosso da Omsa e Izs, da domani al 27 giugno

Capacità controllo infezione in pazienti trattati dall’infanzia

Capacità controllo infezione in pazienti trattati dall’infanzia

Attivato dall’Ail a Foggia:”primi in Italia vicini a difficoltà”

39 quelle firmate dagli oncologi Aiom. Il caso delle terapie neoadiuvanti

A Roma prima edizione di Tobeduca, in ricordo di Fabio Duchini

Farmaco rivoluziona prevenzione. Salgono contagi ma taglio fondi

Coinvolti Austria, Repubblica Ceca, Ungheria e Slovacchia

Dagli esperti del Bambino Gesù, niente sole fino ai 6 mesi